CTOs on the Move

Haemonetics

www.haemonetics.com

 
We believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. We seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. Working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right dose to the patient who does.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion

Executives

Name Title Contact Details
Frank Chan
 Executive Vice President & Chief Operating Officer Profile
Anila Lingamneni
 Executive Vice President and Chief Technology Officer Profile
Kimberly Weatherbee
 Vice President of Information Technology Profile

Funding

Haemonetics raised $700M on 06/18/2018
Haemonetics raised $23M on 05/23/2019
Haemonetics raised $435M on 03/01/2021

Similar Companies

Animas Corporation

Animas Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Us Medical Source

Us Medical Source is a Mount Pleasant, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Emphasys Medical

Emphasys Medical is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Phonic Ear

Phonic Ear is a Petaluma, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sientra

Headquartered in Santa Barbara, California, Sientra offers leading transformative treatments and technologies focused on progressing the art of plastic surgery and making a difference in patients` lives. With unrivaled safety, state-of-the-art science and exceptional service; paired with unparalleled partnerships with plastic surgeons, the Sientra portfolio of proprietary innovations radically advances how plastic surgeons think, work and care for their patients. The company`s core breast products segment includes its state-of-the-art Sientra breast implants and its ground-breaking dual-port breast tissue expander, AlloX2® . In addition, the Sientra portfolio also includes BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons(*) and miraDry, the only non-surgical, FDA-cleared device indicated for the permanent reduction of underarm sweat and hair and may also reduce odor.